310 related articles for article (PubMed ID: 16277695)
41. α-enolase is an antigenic target in primary Sjögren's syndrome.
Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Llorente L; Hernandez-Molina G
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):29-35. PubMed ID: 30418121
[TBL] [Abstract][Full Text] [Related]
42. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
Konig MF; Giles JT; Nigrovic PA; Andrade F
Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
[TBL] [Abstract][Full Text] [Related]
43. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
44. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
[TBL] [Abstract][Full Text] [Related]
45. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.
Corsiero E; Bombardieri M; Carlotti E; Pratesi F; Robinson W; Migliorini P; Pitzalis C
Ann Rheum Dis; 2016 Oct; 75(10):1866-75. PubMed ID: 26659717
[TBL] [Abstract][Full Text] [Related]
46. Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins.
Van Steendam K; Tilleman K; De Ceuleneer M; De Keyser F; Elewaut D; Deforce D
Arthritis Res Ther; 2010; 12(4):R132. PubMed ID: 20609218
[TBL] [Abstract][Full Text] [Related]
47. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
van Venrooij WJ; van de Putte LB
Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
[TBL] [Abstract][Full Text] [Related]
48. Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
Meng X; Ezzati P; Smolik I; Bernstein CN; Hitchon CA; El-Gabalawy HS
PLoS One; 2016; 11(10):e0165501. PubMed ID: 27788229
[TBL] [Abstract][Full Text] [Related]
49. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.
Tilleman K; Van Steendam K; Cantaert T; De Keyser F; Elewaut D; Deforce D
Rheumatology (Oxford); 2008 May; 47(5):597-604. PubMed ID: 18326534
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition.
Amara K; Steen J; Murray F; Morbach H; Fernandez-Rodriguez BM; Joshua V; Engström M; Snir O; Israelsson L; Catrina AI; Wardemann H; Corti D; Meffre E; Klareskog L; Malmström V
J Exp Med; 2013 Mar; 210(3):445-55. PubMed ID: 23440041
[TBL] [Abstract][Full Text] [Related]
51. [Prevalence of antiepithelial cell antibody in systemic vasculitis and identification of the target antigen thereof].
Zheng WJ; Tang FL; Zhao Y; Chen H; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3272-6. PubMed ID: 16409818
[TBL] [Abstract][Full Text] [Related]
52. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.
Vossenaar ER; Després N; Lapointe E; van der Heijden A; Lora M; Senshu T; van Venrooij WJ; Ménard HA
Arthritis Res Ther; 2004; 6(2):R142-50. PubMed ID: 15059278
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of anticitrullinated peptide antibodies and response to anti-tumor necrosis factor agents in rheumatoid arthritis.
Fisher BA; Plant D; Lundberg K; Charles P; Barton A; Venables PJ;
J Rheumatol; 2012 May; 39(5):929-32. PubMed ID: 22467927
[TBL] [Abstract][Full Text] [Related]
54. Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies.
Sorice M; Iannuccelli C; Manganelli V; Capozzi A; Alessandri C; Lococo E; Garofalo T; Di Franco M; Bombardieri M; Nerviani A; Misasi R; Valesini G
Rheumatology (Oxford); 2016 Aug; 55(8):1374-85. PubMed ID: 27074807
[TBL] [Abstract][Full Text] [Related]
55. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
56. Association of citrullinated proteins with synovial exosomes.
Skriner K; Adolph K; Jungblut PR; Burmester GR
Arthritis Rheum; 2006 Dec; 54(12):3809-14. PubMed ID: 17133577
[TBL] [Abstract][Full Text] [Related]
57. Anti-enolase１antibodies from a patient with systemic lupus erythematosus accompanied by pulmonary arterial hypertension promote migration of pulmonary artery smooth muscle cells.
Kato Y; Kasama T; Soejima M; Kubota T
Immunol Lett; 2020 Feb; 218():22-29. PubMed ID: 31866401
[TBL] [Abstract][Full Text] [Related]
58. Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic mice.
Kinloch AJ; Alzabin S; Brintnell W; Wilson E; Barra L; Wegner N; Bell DA; Cairns E; Venables PJ
Arthritis Rheum; 2011 Dec; 63(12):3818-23. PubMed ID: 21953289
[TBL] [Abstract][Full Text] [Related]
59. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease.
Harlow L; Rosas IO; Gochuico BR; Mikuls TR; Dellaripa PF; Oddis CV; Ascherman DP
Arthritis Rheum; 2013 Apr; 65(4):869-79. PubMed ID: 23400887
[TBL] [Abstract][Full Text] [Related]
60. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
Goules JD; Goules AV; Tzioufas AG
Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
